FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034355989> ?p ?o ?g. }

• W2034355989 endingPage "502" @default.
• W2034355989 startingPage "495" @default.
• W2034355989 abstract "Melanoma vaccine treatment appears to slow the progression of melanoma in some patients, particularly in patients in whom it stimulates cellular antimelanoma immune responses. The relationship of vaccine-induced antibody responses to clinical outcome is less clear. The purpose of this study was to investigate the clinical relevance of antibody responses to melanoma vaccine immunization.Eighty-two evaluable patients with surgically resected American Joint Committee on Cancer Stage III malignant melanoma were immunized to a partially purified, polyvalent, melanoma antigen vaccine. Antimelanoma antibodies were measured by immunoprecipitation and sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis before vaccine treatment and 1 week after the fourth immunization.Vaccine treatment induced or augmented antibody responses to melanoma in 32 (39%) of the patients. The antibodies were directed to one or more antigens of 38-43, 75, 110, 150 and/or 210 kDs, which previously have been shown to be expressed preferentially in cultured human melanoma cells. The median disease free survival of patients with a vaccine-induced antibody response to one or more of these antigens was 5.4 years compared with 1.4 years for nonresponders (P = 0.06), and 5-year overall survival was 71% compared with 44%, respectively (P = < 0.01). As determined by Cox multivariate analysis, the difference in overall survival was independent of disease severity or of immunologic competence as evaluated by ability to be sensitized to dinitrochlorobenzene. The difference in survival between antibody responders and nonresponders improved with time.The antibody response to vaccine treatment is an immune marker of vaccine activity that appears to be predictive of a later reduction in the recurrence of melanoma and is unrelated to the vaccine's ability to induce cellular immune responses. This finding suggests that vaccine treatment may be effective in slowing the progression of melanoma in some patients and that the protective effect is mediated partly by vaccine-induced antimelanoma antibodies." @default.
• W2034355989 created "2016-06-24" @default.
• W2034355989 creator A5020456610 @default.
• W2034355989 creator A5039379693 @default.
• W2034355989 creator A5062735077 @default.
• W2034355989 creator A5066476199 @default.
• W2034355989 creator A5066744433 @default.
• W2034355989 creator A5069843850 @default.
• W2034355989 creator A5079917094 @default.
• W2034355989 creator A5089426711 @default.
• W2034355989 date "1995-01-15" @default.
• W2034355989 modified "2023-10-18" @default.
• W2034355989 title "Improved survival of patients with melanoma with an antibody response to immunization to a polyvalent melanoma vaccine" @default.
• W2034355989 cites W1561371846 @default.
• W2034355989 cites W1992875286 @default.
• W2034355989 cites W1998490526 @default.
• W2034355989 cites W2066488467 @default.
• W2034355989 cites W2070718488 @default.
• W2034355989 cites W2081774451 @default.
• W2034355989 cites W2239850217 @default.
• W2034355989 cites W2243393118 @default.
• W2034355989 cites W2330583972 @default.
• W2034355989 cites W4239330499 @default.
• W2034355989 doi "https://doi.org/10.1002/1097-0142(19950115)75:2<495::aid-cncr2820750212>3.0.co;2-s" @default.
• W2034355989 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7812920" @default.
• W2034355989 hasPublicationYear "1995" @default.
• W2034355989 type Work @default.
• W2034355989 sameAs 2034355989 @default.
• W2034355989 citedByCount "59" @default.
• W2034355989 countsByYear W20343559892013 @default.
• W2034355989 countsByYear W20343559892015 @default.
• W2034355989 countsByYear W20343559892021 @default.
• W2034355989 countsByYear W20343559892022 @default.
• W2034355989 crossrefType "journal-article" @default.
• W2034355989 hasAuthorship W2034355989A5020456610 @default.
• W2034355989 hasAuthorship W2034355989A5039379693 @default.
• W2034355989 hasAuthorship W2034355989A5062735077 @default.
• W2034355989 hasAuthorship W2034355989A5066476199 @default.
• W2034355989 hasAuthorship W2034355989A5066744433 @default.
• W2034355989 hasAuthorship W2034355989A5069843850 @default.
• W2034355989 hasAuthorship W2034355989A5079917094 @default.
• W2034355989 hasAuthorship W2034355989A5089426711 @default.
• W2034355989 hasConcept C147483822 @default.
• W2034355989 hasConcept C159654299 @default.
• W2034355989 hasConcept C203014093 @default.
• W2034355989 hasConcept C2777658100 @default.
• W2034355989 hasConcept C2777701055 @default.
• W2034355989 hasConcept C2780801004 @default.
• W2034355989 hasConcept C502942594 @default.
• W2034355989 hasConcept C71924100 @default.
• W2034355989 hasConcept C8891405 @default.
• W2034355989 hasConceptScore W2034355989C147483822 @default.
• W2034355989 hasConceptScore W2034355989C159654299 @default.
• W2034355989 hasConceptScore W2034355989C203014093 @default.
• W2034355989 hasConceptScore W2034355989C2777658100 @default.
• W2034355989 hasConceptScore W2034355989C2777701055 @default.
• W2034355989 hasConceptScore W2034355989C2780801004 @default.
• W2034355989 hasConceptScore W2034355989C502942594 @default.
• W2034355989 hasConceptScore W2034355989C71924100 @default.
• W2034355989 hasConceptScore W2034355989C8891405 @default.
• W2034355989 hasIssue "2" @default.
• W2034355989 hasLocation W20343559891 @default.
• W2034355989 hasLocation W20343559892 @default.
• W2034355989 hasOpenAccess W2034355989 @default.
• W2034355989 hasPrimaryLocation W20343559891 @default.
• W2034355989 hasRelatedWork W1484759019 @default.
• W2034355989 hasRelatedWork W1972479046 @default.
• W2034355989 hasRelatedWork W2025941271 @default.
• W2034355989 hasRelatedWork W2150135081 @default.
• W2034355989 hasRelatedWork W2220102944 @default.
• W2034355989 hasRelatedWork W2409441623 @default.
• W2034355989 hasRelatedWork W2903752946 @default.
• W2034355989 hasRelatedWork W3158438576 @default.
• W2034355989 hasRelatedWork W4313376859 @default.
• W2034355989 hasRelatedWork W1926304844 @default.
• W2034355989 hasVolume "75" @default.
• W2034355989 isParatext "false" @default.
• W2034355989 isRetracted "false" @default.
• W2034355989 magId "2034355989" @default.
• W2034355989 workType "article" @default.